Axim Biotechnologies Inc (PK) (AXIM)
USOTC
News
Market Data
Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
The current AXIM market cap is 528.43k. The company's latest EPS is USD -0.0267 and P/E is 0.00.
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 799k | 0 | 60k | 9k | 39k |
| Operating Income | -6.51M | -4.95M | -8.01M | -4.65M | -2.75M |
| Net Income | -6.45M | -6.29M | -16.03M | -6.24M | -8.06M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 1.69M | 11.31M | 5.32M | 4.21M | 4.12M |
| Total Liabilities | 8.45M | 9.75M | 7.66M | 9.04M | 11.78M |
| Total Equity | -6.76M | 1.57M | -2.34M | -4.83M | -7.66M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -5.02M | -3.22M | -2.49M | -2.04M | -1.03M |
| Investing | 349k | 10k | -50k | -9k | N/A |
| Financing | 3.38M | 3.15M | 2.53M | 1.65M | 1.14M |
| Market Cap | 528.43k |
| Price to Earnings Ratio | 0.00 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 0 |
| Price to Book Ratio | 0 |
| Dividend Yield | - |
| Shares Outstanding | 301.96M |
| Average Volume (1 week) | 1.37M |
| Average Volume (1 Month) | 1.32M |
| 52 Week Change | -90.28% |
| 52 Week High | 0.0203 |
| 52 Week Low | 0.0013 |
| Spread (Intraday) | 0 (11.11%) |
| Company Name | Axim Biotechnologies Inc (PK) |
| Address |
401 ryland st reno, nevada 89502 |
| Website | https://www.aximbiotech.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
